Lenstec, Inc.
  • Home
  • About Us
    • Company History
    • Locations
    • Regulatory Registrations
  • Products
    • International >
      • Softec Series IOLs >
        • Softec HD >
          • Technical Specifications
          • Resources
          • Testimonials
        • Softec HDM >
          • Technical Specifications
        • Softec HD3
        • Softec I >
          • Technical Specifications
          • Resources
        • Softec HDY >
          • Technical Specifications
          • Resources
        • Softec HDO >
          • Technical Specifications
          • Resources
      • Softec HP1
      • SBL-2 >
        • Technical Specifications
        • Resources
      • SBL-3 >
        • Technical Specifications
        • Resources
      • Tetraflex HD >
        • Technical Specifications
        • Resources
      • PMMA Lenses
      • Surgical Knives
      • Capsular Tension Rings
      • Instruments/Delivery System >
        • Resources
    • U.S.A. >
      • Softec HD >
        • Technical Specifications
        • Resources
        • Testimonials
      • Softec HDO >
        • Technical Specifications
        • Resources
      • Softec HDM >
        • Technical Specifications
      • Softec I >
        • Technical Specifications
        • Resources
      • ClearView3 >
        • Technical SpecificationsCV
        • ResourcesCV
      • Instruments/Delivery System >
        • Resources
    • Instructions for Use
    • VideoTestimonials >
      • Tyson
      • Harvey
      • Desai
      • Woodcock
      • Wortz
      • Matossian
  • News
  • Customers
  • Contact Us

First FDA approved ClearView 3 Multifocal Intraocular Lens implanted in U.S.

8/15/2022

 
Picture
​Lenstec, Inc. (St. Petersburg, FL) is proud to announce today, that the first U.S. commercial implantations of their newly FDA approved SBL-3 ClearViewTM Multifocal Intraocular lens (MIOL) were performed by Jeff Whitsett, MD of Whitsett Vision (Houston, TX).
 
The SBL-3 Clearview Multifocal is a next generation presbyopia correcting IOL design, that in FDA clinical trials provided patients with near, intermediate and distance vision, with reports of much lower visual disturbances than traditional MIOLs. Additionally, over 90% of patients achieved binocular visual acuities of 20/25 or better at all distances, as well as over 93% reporting spectacle independence.
 
Dr. Whitsett served as a principal investigator in FDA trials of the ClearView MIOL. He notes, “Patients have reported high levels of satisfaction with minimal side effects.  I believe the SBL-3 ClearView MIOL will be an excellent option for refractive lens surgeons.”
 
"Lenstec is proud to have a surgeon of Dr Whitsett's caliber be the first to implant our new ClearView MIOL in the US," says Jimmy Chacko, Vice President of Regulatory Affairs at Lenstec. "Years of clinical trial work by him and his staff helped catapult Lenstec into the presbyopia correction arena. We look forward to his continued use and exceptional outcomes for his patients"
 
About Whitsett Vision Group
 
Jeffrey Whitsett, MD founded Whitsett Vision Group in 1999, with a goal of bringing superior eye care and surgical vision treatment options to the city of Houston. Dr. Whitsett specializes in custom cataract surgery and custom LASIK, focusing on providing patients with the best visual outcomes after surgery. He has had incredible success in helping patients become glasses-free after surgery.
 
About Lenstec
 
Lenstec is a leading designer and manufacturer of intraocular Lenses (IOLs) to treat patients with a range of vision disorders. Founded in 1992, the company is dedicated to advancing possibilities for ophthalmic professionals and their patients worldwide.


Comments are closed.

    Archives

    March 2023
    February 2023
    January 2023
    December 2022
    November 2022
    October 2022
    September 2022
    August 2022
    July 2022
    July 2021
    November 2020
    March 2020
    September 2019
    August 2019
    May 2019
    August 2018
    May 2018
    March 2018
    May 2017
    February 2017
    April 2016
    August 2015
    January 2015
    October 2014
    May 2014
    April 2014
    November 2013
    May 2013
    April 2013
    March 2012

    RSS Feed

World Headquarters

Lenstec, Inc.
1765 Commerce Ave. N.
St. Petersburg, FL 33716 USA
Tel: +1 727-571-2272
Fax: +1 727-571-1792



U.S. CUSTOMER SERVICE:
TEL: 1-866-536-7832
FAX: 1-866-536-3040

​Lenstec Barbados

Lenstec (Barbados) Inc.
Airport Commercial Centre
Pilgrim Road
Christ Church, Barbados BB17092
Tel: 246-420-6795
Fax: 246-420-6797



​


LENSTEC UK

LENSTEC (BARBADOS) INC.
LENSTEC HOUSE
UNIT 8, MARINER House
CALDER PARK
WAKEFIELD

West Yorkshire wf4 3fl
ENGLAND
​
TEL: +44 (0)1924 382 678
FAX:+44 (0)1924 850 454
​


EUROPEAN REGIONAL OFFICE

TRENCIANSKA 47
821 09 BRATISLAVA
SLOVAK REPUBLIC

TEL: 00421905798760





​

​INDICATION 
The Lenstec Softec Aspheric Posterior Chamber Intraocular Lens is intended for the replacement of the human crystalline lens following phacoemulsification cataract removal in adults over the age of 21. The lens is indicated for capsular bag placement.
CAUTION: Federal (U.S.) law restricts some of these devices to the sale by or on the order of a physician.
Lenstec, Inc. is an ISO 13485 company manufacturing CE Marked Products with additional registrations of several countries.
​DUNS: 807554100
© 2021 Lenstec, Inc. All Rights Reserved. Lenstec, Softec, Softec HD, Tetraflex, SBL-3, and the Softec HD logo are registered trademarks of Lenstec, Inc.